Active ingredient
Ocrelizumab NDC Codes
Ocrelizumab is an active ingredient in 2 finished products listed with the FDA, under 2 names.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Brand and generic names
- Ocrevus Zunovo, Ocrevus
- Labelers
- Genentech, Inc.
- Strengths
- Ocrelizumab 920 mg/23mL; Hyaluronidase (Human recombinant) 23000 U/23mL; Ocrelizumab 300 mg/10mL
- Dosage forms
- Injection, Solution, Injection
- Routes
- Subcutaneous, Intravenous
- Drug classes (FDA established)
- CD20-directed Cytolytic Antibody, Endoglycosidase
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 3
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|
| Ocrevus Zunovoocrelizumab and hyaluronidase | Ocrelizumab 920 mg/23mL; Hyaluronidase (Human recombinant) 23000 U/23mL | Injection, SolutionSubcutaneous | Genentech, Inc. | 50242-554 | 50242-0554-0150242-0554-86 | — |
| Ocrevusocrelizumab | Ocrelizumab 300 mg/10mL | InjectionIntravenous | Genentech, Inc. | 50242-150 | 50242-0150-01 | — |
Ocrelizumab: common questions
- Which drugs contain Ocrelizumab?
- Ocrevus Zunovo, Ocrevus.
- Is there a J-code for Ocrelizumab?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.